This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Juvic Inc., Yonsei University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 11 
1 out of 1,486 
Years Active: 2026
Title: Geonwoo Kang: Innovator in Microneedle Vaccine Technology
Introduction
Geonwoo Kang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of vaccine delivery systems, particularly through his innovative work on microneedles.
Latest Patents
Geonwoo Kang holds a patent for a microneedle containing an influenza vaccine. This invention relates to a soluble microneedle that enhances the stability of the influenza vaccine. The microneedle includes a water-soluble polymer and an additive in a specific ratio, which not only increases the stability of the vaccine but also improves skin penetration and drug delivery effectiveness.
Career Highlights
Throughout his career, Geonwoo Kang has worked with notable institutions, including Yonsei University and Juvic Inc. His research and development efforts have focused on advancing vaccine technologies to improve public health outcomes.
Collaborations
Geonwoo Kang has collaborated with colleagues such as Hyungil Jung and Huisuk Yang, contributing to the advancement of microneedle technology and its applications in vaccine delivery.
Conclusion
Geonwoo Kang's innovative work in microneedle technology represents a significant advancement in vaccine delivery systems. His contributions are poised to enhance the effectiveness and accessibility of influenza vaccinations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile